Document is current
Any future updates will be listed below
-
Authors
Diekhoff, Torsten https://orcid.org/0000-0003-3593-1449
Ulas, Sevtap Tugce
-
Funding
Funding for this research was provided by:
Medizinische Hochschule Brandenburg CAMPUS GmbH
- License Information
-
More Information
Article History
Received: 4 December 2024
Revised: 8 April 2025
Accepted: 8 April 2025
First Online: 16 April 2025
Declarations
:
: Not applicable.
: TD: speaker: Novartis, MSD, UCB, Janssen, Eli Lilly, Canon MS, Berlinflame, Bracco; Advisory board: Eli Lilly, AbbVie, UCB; TU: none were declared.
